Skip to main content
. 2019 Jan 17;9:189. doi: 10.1038/s41598-018-37406-9

Figure 1.

Figure 1

(A) Distribution of haptoglobin (Hp) phenotypes in healthy subjects and in chronic obstructive pulmonary disease (COPD) GOLD 1 + 2 and GOLD 3 + 4 patients. (B) Serum concentrations of Hp phenotypes in healthy subjects and COPD GOLD 1 + 2 and GOLD 3 + 4 patients. *p < 0.05; **p < 0.01; ***p < 0.001.